

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.41388996 |
| 2 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.17950237 |
| 3 | synaptic vesicle maturation (GO:0016188) | 5.00664649 |
| 4 | vocalization behavior (GO:0071625) | 4.97509752 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 4.93547168 |
| 6 | locomotory exploration behavior (GO:0035641) | 4.90984631 |
| 7 | neuron cell-cell adhesion (GO:0007158) | 4.87783383 |
| 8 | behavioral response to nicotine (GO:0035095) | 4.86625462 |
| 9 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.85895831 |
| 10 | glutamate secretion (GO:0014047) | 4.71378252 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.71336315 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.60822673 |
| 13 | protein localization to synapse (GO:0035418) | 4.51045690 |
| 14 | cAMP catabolic process (GO:0006198) | 4.46475593 |
| 15 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.29498768 |
| 16 | cyclic nucleotide catabolic process (GO:0009214) | 4.26242042 |
| 17 | detection of light stimulus involved in sensory perception (GO:0050962) | 4.23955490 |
| 18 | detection of light stimulus involved in visual perception (GO:0050908) | 4.23955490 |
| 19 | exploration behavior (GO:0035640) | 4.23207410 |
| 20 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.22842767 |
| 21 | regulation of synaptic vesicle transport (GO:1902803) | 4.20202443 |
| 22 | neuronal action potential propagation (GO:0019227) | 4.15671482 |
| 23 | fucose catabolic process (GO:0019317) | 4.02917796 |
| 24 | L-fucose metabolic process (GO:0042354) | 4.02917796 |
| 25 | L-fucose catabolic process (GO:0042355) | 4.02917796 |
| 26 | neurotransmitter secretion (GO:0007269) | 4.01836198 |
| 27 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 4.00393829 |
| 28 | acrosome assembly (GO:0001675) | 3.98933319 |
| 29 | layer formation in cerebral cortex (GO:0021819) | 3.98419780 |
| 30 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.97815106 |
| 31 | glutamate receptor signaling pathway (GO:0007215) | 3.97718963 |
| 32 | synaptic transmission, glutamatergic (GO:0035249) | 3.92470656 |
| 33 | neuron-neuron synaptic transmission (GO:0007270) | 3.87487713 |
| 34 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.83207922 |
| 35 | auditory behavior (GO:0031223) | 3.80262415 |
| 36 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.78736286 |
| 37 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.73102250 |
| 38 | proline transport (GO:0015824) | 3.72010104 |
| 39 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.71135215 |
| 40 | neuron recognition (GO:0008038) | 3.69757464 |
| 41 | regulation of hippo signaling (GO:0035330) | 3.68588436 |
| 42 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.67577561 |
| 43 | regulation of synapse structural plasticity (GO:0051823) | 3.67095774 |
| 44 | positive regulation of membrane potential (GO:0045838) | 3.63779424 |
| 45 | neuronal action potential (GO:0019228) | 3.58942904 |
| 46 | neurotransmitter transport (GO:0006836) | 3.53765877 |
| 47 | dendritic spine morphogenesis (GO:0060997) | 3.53638683 |
| 48 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.51412217 |
| 49 | protein polyglutamylation (GO:0018095) | 3.50721511 |
| 50 | gamma-aminobutyric acid transport (GO:0015812) | 3.47420057 |
| 51 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.41192118 |
| 52 | innervation (GO:0060384) | 3.40654257 |
| 53 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.40184630 |
| 54 | postsynaptic membrane organization (GO:0001941) | 3.38612774 |
| 55 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.38419742 |
| 56 | cellular potassium ion homeostasis (GO:0030007) | 3.38000399 |
| 57 | long-term memory (GO:0007616) | 3.35951767 |
| 58 | positive regulation of synapse maturation (GO:0090129) | 3.33412588 |
| 59 | response to auditory stimulus (GO:0010996) | 3.31116351 |
| 60 | transmission of nerve impulse (GO:0019226) | 3.29799298 |
| 61 | negative regulation of Rho protein signal transduction (GO:0035024) | 3.28357917 |
| 62 | presynaptic membrane assembly (GO:0097105) | 3.27986267 |
| 63 | axonal fasciculation (GO:0007413) | 3.27603061 |
| 64 | establishment of protein localization to Golgi (GO:0072600) | 3.27338349 |
| 65 | auditory receptor cell differentiation (GO:0042491) | 3.26066879 |
| 66 | behavioral response to ethanol (GO:0048149) | 3.25545085 |
| 67 | regulation of postsynaptic membrane potential (GO:0060078) | 3.24941726 |
| 68 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.23773278 |
| 69 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.23411194 |
| 70 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.20262608 |
| 71 | startle response (GO:0001964) | 3.18820746 |
| 72 | regulation of neurotransmitter levels (GO:0001505) | 3.17508100 |
| 73 | cell migration in hindbrain (GO:0021535) | 3.17484507 |
| 74 | synaptic vesicle endocytosis (GO:0048488) | 3.16430882 |
| 75 | dendrite morphogenesis (GO:0048813) | 3.15819324 |
| 76 | glycosphingolipid biosynthetic process (GO:0006688) | 3.15397336 |
| 77 | regulation of neurotransmitter secretion (GO:0046928) | 3.15271152 |
| 78 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.15258394 |
| 79 | regulation of synaptic plasticity (GO:0048167) | 3.14998042 |
| 80 | axoneme assembly (GO:0035082) | 3.14410702 |
| 81 | mechanosensory behavior (GO:0007638) | 3.13906868 |
| 82 | indolalkylamine catabolic process (GO:0046218) | 3.13039457 |
| 83 | tryptophan catabolic process (GO:0006569) | 3.13039457 |
| 84 | indole-containing compound catabolic process (GO:0042436) | 3.13039457 |
| 85 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.13029181 |
| 86 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.12453215 |
| 87 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.12382655 |
| 88 | synapse assembly (GO:0007416) | 3.12299427 |
| 89 | regulation of vesicle fusion (GO:0031338) | 3.11947215 |
| 90 | C4-dicarboxylate transport (GO:0015740) | 3.09361078 |
| 91 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.08843137 |
| 92 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.08367394 |
| 93 | kynurenine metabolic process (GO:0070189) | 3.07142390 |
| 94 | presynaptic membrane organization (GO:0097090) | 3.05968191 |
| 95 | behavioral defense response (GO:0002209) | 3.05855366 |
| 96 | behavioral fear response (GO:0001662) | 3.05855366 |
| 97 | detection of calcium ion (GO:0005513) | 3.05153967 |
| 98 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.04067947 |
| 99 | long-term synaptic potentiation (GO:0060291) | 3.03617170 |
| 100 | positive regulation of fatty acid transport (GO:2000193) | 2.99668872 |
| 101 | prepulse inhibition (GO:0060134) | 2.99621738 |
| 102 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.97994056 |
| 103 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.96818676 |
| 104 | retinal cone cell development (GO:0046549) | 2.96465426 |
| 105 | regulation of neurotransmitter transport (GO:0051588) | 2.95510340 |
| 106 | response to histamine (GO:0034776) | 2.95333393 |
| 107 | positive regulation of neurotransmitter transport (GO:0051590) | 2.94718555 |
| 108 | glycine transport (GO:0015816) | 2.94312893 |
| 109 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.93431739 |
| 110 | membrane hyperpolarization (GO:0060081) | 2.93029167 |
| 111 | protein targeting to Golgi (GO:0000042) | 2.93013479 |
| 112 | indolalkylamine metabolic process (GO:0006586) | 2.92553973 |
| 113 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.92508244 |
| 114 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.91122290 |
| 115 | protein localization to cilium (GO:0061512) | 2.89963916 |
| 116 | cellular ketone body metabolic process (GO:0046950) | 2.88843296 |
| 117 | activation of protein kinase A activity (GO:0034199) | 2.88209135 |
| 118 | cochlea development (GO:0090102) | 2.87556353 |
| 119 | fear response (GO:0042596) | 2.87546910 |
| 120 | dendritic spine organization (GO:0097061) | 2.86255146 |
| 121 | response to pheromone (GO:0019236) | 2.85225685 |
| 122 | synaptic transmission (GO:0007268) | 2.85172097 |
| 123 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.83669721 |
| 124 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.83406896 |
| 125 | neuromuscular process controlling balance (GO:0050885) | 2.83183586 |
| 126 | membrane depolarization (GO:0051899) | 2.82720266 |
| 127 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.81892840 |
| 128 | regulation of cilium movement (GO:0003352) | 2.81303487 |
| 129 | learning (GO:0007612) | 2.81030234 |
| 130 | behavioral response to cocaine (GO:0048148) | 2.80886740 |
| 131 | intraspecies interaction between organisms (GO:0051703) | 2.80519557 |
| 132 | social behavior (GO:0035176) | 2.80519557 |
| 133 | epithelial cilium movement (GO:0003351) | 2.80509523 |
| 134 | membrane depolarization during action potential (GO:0086010) | 2.80261855 |
| 135 | synapse organization (GO:0050808) | 2.80112009 |
| 136 | positive regulation of dendritic spine development (GO:0060999) | 2.80016443 |
| 137 | regulation of dendritic spine development (GO:0060998) | 2.78561653 |
| 138 | DNA deamination (GO:0045006) | 2.78479371 |
| 139 | regulation of synapse maturation (GO:0090128) | 2.76435909 |
| 140 | protein localization to Golgi apparatus (GO:0034067) | 2.75756952 |
| 141 | nucleobase catabolic process (GO:0046113) | 2.73872779 |
| 142 | cilium morphogenesis (GO:0060271) | 2.71389607 |
| 143 | sulfation (GO:0051923) | 2.71240738 |
| 144 | serotonin metabolic process (GO:0042428) | 2.70758614 |
| 145 | regulation of uterine smooth muscle contraction (GO:0070472) | 2.70698273 |
| 146 | regulation of gene silencing by RNA (GO:0060966) | 2.68492177 |
| 147 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.68492177 |
| 148 | regulation of gene silencing by miRNA (GO:0060964) | 2.68492177 |
| 149 | protein K11-linked deubiquitination (GO:0035871) | 2.67181215 |
| 150 | cGMP metabolic process (GO:0046068) | 2.65813863 |
| 151 | calcium ion import (GO:0070509) | 2.61455671 |
| 152 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.60916106 |
| 153 | tryptophan metabolic process (GO:0006568) | 2.60243505 |
| 154 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.59349404 |
| 155 | regulation of action potential (GO:0098900) | 2.58225369 |
| 156 | indole-containing compound metabolic process (GO:0042430) | 2.57302755 |
| 157 | cilium movement (GO:0003341) | 2.56507773 |
| 158 | positive regulation of icosanoid secretion (GO:0032305) | 2.54075634 |
| 159 | primary amino compound metabolic process (GO:1901160) | 2.53746670 |
| 160 | action potential (GO:0001508) | 2.53621733 |
| 161 | ketone body metabolic process (GO:1902224) | 2.52882658 |
| 162 | cardiac right ventricle morphogenesis (GO:0003215) | 2.51024639 |
| 163 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.50462961 |
| 164 | multicellular organism reproduction (GO:0032504) | 2.50128778 |
| 165 | neurotransmitter metabolic process (GO:0042133) | 2.49712517 |
| 166 | regulation of hexokinase activity (GO:1903299) | 2.48867591 |
| 167 | regulation of glucokinase activity (GO:0033131) | 2.48867591 |
| 168 | piRNA metabolic process (GO:0034587) | 2.48492522 |
| 169 | regulation of protein kinase A signaling (GO:0010738) | 2.47471376 |
| 170 | cilium organization (GO:0044782) | 2.47088378 |
| 171 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.46608616 |
| 172 | adaptation of signaling pathway (GO:0023058) | 2.45704513 |
| 173 | negative regulation of mast cell activation (GO:0033004) | 2.44453960 |
| 174 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.42972086 |
| 175 | cilium assembly (GO:0042384) | 2.42935857 |
| 176 | platelet dense granule organization (GO:0060155) | 2.41769186 |
| 177 | inner ear receptor stereocilium organization (GO:0060122) | 2.41656863 |
| 178 | rhodopsin mediated signaling pathway (GO:0016056) | 2.40171660 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.57234723 |
| 2 | * GBX2_23144817_ChIP-Seq_PC3_Human | 3.82567804 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.99836486 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.97676815 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.82368559 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.61582805 |
| 7 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.50709258 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.50605860 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.50605860 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.50210665 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.46717558 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.38767584 |
| 13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.36909984 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.33526874 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.28474027 |
| 16 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.15395168 |
| 17 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.14601526 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.14542941 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.13730137 |
| 20 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.13489393 |
| 21 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.11075938 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.07738614 |
| 23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.06145325 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.04068222 |
| 25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.03212237 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.02645940 |
| 27 | EWS_26573619_Chip-Seq_HEK293_Human | 1.97456052 |
| 28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.93971450 |
| 29 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.91639694 |
| 30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.86983927 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.82172545 |
| 32 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.77763950 |
| 33 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.75705718 |
| 34 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.74701377 |
| 35 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.72464117 |
| 36 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.62314137 |
| 37 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.61862229 |
| 38 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.61106404 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.60358407 |
| 40 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.59191464 |
| 41 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.57390203 |
| 42 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.54124662 |
| 43 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.53931106 |
| 44 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.52669426 |
| 45 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.52669426 |
| 46 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.50922896 |
| 47 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.46201525 |
| 48 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.42923050 |
| 49 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.40524752 |
| 50 | VDR_22108803_ChIP-Seq_LS180_Human | 1.40293204 |
| 51 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.39697755 |
| 52 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.39681787 |
| 53 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.38361308 |
| 54 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.38159091 |
| 55 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.36254860 |
| 56 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32757088 |
| 57 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.32497506 |
| 58 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.32436851 |
| 59 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29825929 |
| 60 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.28606273 |
| 61 | FUS_26573619_Chip-Seq_HEK293_Human | 1.28390421 |
| 62 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27882033 |
| 63 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27510475 |
| 64 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.27186350 |
| 65 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.26609142 |
| 66 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.26170426 |
| 67 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.25012692 |
| 68 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.24596980 |
| 69 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.23864044 |
| 70 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.23864044 |
| 71 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.23511697 |
| 72 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.23327408 |
| 73 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.22687688 |
| 74 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.21757430 |
| 75 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.20428904 |
| 76 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.20222755 |
| 77 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.19813213 |
| 78 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.18154538 |
| 79 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.17678895 |
| 80 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17366869 |
| 81 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.16817184 |
| 82 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.16661402 |
| 83 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.15523648 |
| 84 | AR_19668381_ChIP-Seq_PC3_Human | 1.15093972 |
| 85 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.14686034 |
| 86 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.14437304 |
| 87 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.13492102 |
| 88 | TP53_16413492_ChIP-PET_HCT116_Human | 1.13125169 |
| 89 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.12194183 |
| 90 | TCF4_23295773_ChIP-Seq_U87_Human | 1.12160257 |
| 91 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.12057141 |
| 92 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.10806038 |
| 93 | RXR_22108803_ChIP-Seq_LS180_Human | 1.10581025 |
| 94 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.10145120 |
| 95 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.09059609 |
| 96 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.08654443 |
| 97 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.07849881 |
| 98 | JUN_21703547_ChIP-Seq_K562_Human | 1.07187197 |
| 99 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.06302116 |
| 100 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.06238900 |
| 101 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05725807 |
| 102 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.05339108 |
| 103 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.04542271 |
| 104 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.03906567 |
| 105 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03781857 |
| 106 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03645724 |
| 107 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.03488644 |
| 108 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.03174911 |
| 109 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.02651545 |
| 110 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.02218638 |
| 111 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01809219 |
| 112 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.01425622 |
| 113 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00566536 |
| 114 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.00462133 |
| 115 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.00215628 |
| 116 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.99374509 |
| 117 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.99127017 |
| 118 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97874886 |
| 119 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.97874886 |
| 120 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.97354792 |
| 121 | KDM2B_26808549_Chip-Seq_REH_Human | 0.94999576 |
| 122 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.94965371 |
| 123 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.94698465 |
| 124 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.93862009 |
| 125 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.93365524 |
| 126 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92995059 |
| 127 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.92899560 |
| 128 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91710561 |
| 129 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.91710162 |
| 130 | * ER_23166858_ChIP-Seq_MCF-7_Human | 0.90822484 |
| 131 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89302411 |
| 132 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88433064 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.69417301 |
| 2 | MP0003880_abnormal_central_pattern | 4.46898643 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.79170191 |
| 4 | MP0004270_analgesia | 3.72229839 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.12652492 |
| 6 | MP0009745_abnormal_behavioral_response | 3.11102917 |
| 7 | MP0001968_abnormal_touch/_nociception | 3.11045222 |
| 8 | MP0002064_seizures | 2.75808092 |
| 9 | MP0002734_abnormal_mechanical_nocicepti | 2.71426956 |
| 10 | MP0002736_abnormal_nociception_after | 2.69574820 |
| 11 | MP0009046_muscle_twitch | 2.68969221 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.62566348 |
| 13 | MP0002735_abnormal_chemical_nociception | 2.52007840 |
| 14 | MP0001486_abnormal_startle_reflex | 2.44945965 |
| 15 | MP0008877_abnormal_DNA_methylation | 2.44324024 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.41415936 |
| 17 | MP0002272_abnormal_nervous_system | 2.36175681 |
| 18 | MP0003136_yellow_coat_color | 2.32593525 |
| 19 | MP0002733_abnormal_thermal_nociception | 2.17721928 |
| 20 | MP0002822_catalepsy | 2.09877330 |
| 21 | MP0001440_abnormal_grooming_behavior | 2.08087863 |
| 22 | MP0006276_abnormal_autonomic_nervous | 2.07574467 |
| 23 | MP0002067_abnormal_sensory_capabilities | 2.02796768 |
| 24 | MP0001970_abnormal_pain_threshold | 1.98281910 |
| 25 | MP0000778_abnormal_nervous_system | 1.98252846 |
| 26 | MP0004133_heterotaxia | 1.96970519 |
| 27 | MP0002928_abnormal_bile_duct | 1.94422626 |
| 28 | MP0002184_abnormal_innervation | 1.90989100 |
| 29 | MP0004043_abnormal_pH_regulation | 1.87369812 |
| 30 | MP0001501_abnormal_sleep_pattern | 1.78737615 |
| 31 | MP0001529_abnormal_vocalization | 1.75667307 |
| 32 | MP0002557_abnormal_social/conspecific_i | 1.74892427 |
| 33 | MP0005646_abnormal_pituitary_gland | 1.74752126 |
| 34 | MP0008875_abnormal_xenobiotic_pharmacok | 1.72497203 |
| 35 | MP0005386_behavior/neurological_phenoty | 1.72373880 |
| 36 | MP0004924_abnormal_behavior | 1.72373880 |
| 37 | MP0004147_increased_porphyrin_level | 1.68971988 |
| 38 | MP0001984_abnormal_olfaction | 1.66759812 |
| 39 | MP0003329_amyloid_beta_deposits | 1.64823790 |
| 40 | MP0009780_abnormal_chondrocyte_physiolo | 1.64592028 |
| 41 | MP0003879_abnormal_hair_cell | 1.61177060 |
| 42 | MP0003252_abnormal_bile_duct | 1.59043665 |
| 43 | MP0004811_abnormal_neuron_physiology | 1.56573530 |
| 44 | MP0005174_abnormal_tail_pigmentation | 1.55289314 |
| 45 | MP0005084_abnormal_gallbladder_morpholo | 1.53472557 |
| 46 | MP0001905_abnormal_dopamine_level | 1.52632583 |
| 47 | MP0001986_abnormal_taste_sensitivity | 1.49625540 |
| 48 | MP0004858_abnormal_nervous_system | 1.48186824 |
| 49 | MP0000955_abnormal_spinal_cord | 1.47908169 |
| 50 | MP0002909_abnormal_adrenal_gland | 1.46906798 |
| 51 | MP0004885_abnormal_endolymph | 1.46348041 |
| 52 | MP0008569_lethality_at_weaning | 1.43728284 |
| 53 | MP0005253_abnormal_eye_physiology | 1.43568388 |
| 54 | MP0002066_abnormal_motor_capabilities/c | 1.41988523 |
| 55 | MP0003787_abnormal_imprinting | 1.41434090 |
| 56 | MP0002138_abnormal_hepatobiliary_system | 1.41350217 |
| 57 | MP0002882_abnormal_neuron_morphology | 1.38807344 |
| 58 | MP0001502_abnormal_circadian_rhythm | 1.37694032 |
| 59 | MP0001188_hyperpigmentation | 1.34252116 |
| 60 | MP0004142_abnormal_muscle_tone | 1.31744908 |
| 61 | MP0000372_irregular_coat_pigmentation | 1.31222240 |
| 62 | MP0010386_abnormal_urinary_bladder | 1.28802844 |
| 63 | MP0002163_abnormal_gland_morphology | 1.26098584 |
| 64 | MP0003646_muscle_fatigue | 1.25144631 |
| 65 | MP0002938_white_spotting | 1.24952935 |
| 66 | MP0004742_abnormal_vestibular_system | 1.24893452 |
| 67 | MP0005645_abnormal_hypothalamus_physiol | 1.21276715 |
| 68 | MP0005085_abnormal_gallbladder_physiolo | 1.16774250 |
| 69 | MP0002234_abnormal_pharynx_morphology | 1.15275821 |
| 70 | MP0000427_abnormal_hair_cycle | 1.14175418 |
| 71 | MP0003633_abnormal_nervous_system | 1.10932699 |
| 72 | MP0002152_abnormal_brain_morphology | 1.07914694 |
| 73 | MP0008789_abnormal_olfactory_epithelium | 1.06688904 |
| 74 | MP0002837_dystrophic_cardiac_calcinosis | 1.06297857 |
| 75 | MP0001963_abnormal_hearing_physiology | 1.05746428 |
| 76 | MP0005195_abnormal_posterior_eye | 1.04772860 |
| 77 | MP0001765_abnormal_ion_homeostasis | 1.04586560 |
| 78 | MP0000631_abnormal_neuroendocrine_gland | 1.02302615 |
| 79 | MP0005332_abnormal_amino_acid | 1.02101634 |
| 80 | MP0002229_neurodegeneration | 1.01193822 |
| 81 | MP0002069_abnormal_eating/drinking_beha | 1.00503063 |
| 82 | MP0005379_endocrine/exocrine_gland_phen | 0.99683527 |
| 83 | MP0005551_abnormal_eye_electrophysiolog | 0.99600505 |
| 84 | MP0001485_abnormal_pinna_reflex | 0.98169418 |
| 85 | MP0002102_abnormal_ear_morphology | 0.97561478 |
| 86 | MP0002638_abnormal_pupillary_reflex | 0.96789536 |
| 87 | MP0003121_genomic_imprinting | 0.96207753 |
| 88 | MP0003631_nervous_system_phenotype | 0.95165910 |
| 89 | MP0005535_abnormal_body_temperature | 0.94859110 |
| 90 | MP0000230_abnormal_systemic_arterial | 0.94777003 |
| 91 | MP0003122_maternal_imprinting | 0.94146369 |
| 92 | MP0000751_myopathy | 0.94099955 |
| 93 | MP0008961_abnormal_basal_metabolism | 0.93982096 |
| 94 | MP0004145_abnormal_muscle_electrophysio | 0.93322083 |
| 95 | MP0002752_abnormal_somatic_nervous | 0.92949387 |
| 96 | MP0003950_abnormal_plasma_membrane | 0.91551784 |
| 97 | MP0008872_abnormal_physiological_respon | 0.89636400 |
| 98 | MP0003283_abnormal_digestive_organ | 0.86727334 |
| 99 | MP0004215_abnormal_myocardial_fiber | 0.85383828 |
| 100 | MP0002095_abnormal_skin_pigmentation | 0.84624025 |
| 101 | MP0005220_abnormal_exocrine_pancreas | 0.83917066 |
| 102 | MP0002160_abnormal_reproductive_system | 0.81728002 |
| 103 | MP0002876_abnormal_thyroid_physiology | 0.80955377 |
| 104 | MP0008775_abnormal_heart_ventricle | 0.80141952 |
| 105 | MP0000026_abnormal_inner_ear | 0.79848756 |
| 106 | MP0003011_delayed_dark_adaptation | 0.78685783 |
| 107 | MP0004233_abnormal_muscle_weight | 0.78426232 |
| 108 | MP0005394_taste/olfaction_phenotype | 0.78407018 |
| 109 | MP0005499_abnormal_olfactory_system | 0.78407018 |
| 110 | MP0006072_abnormal_retinal_apoptosis | 0.77998962 |
| 111 | MP0004484_altered_response_of | 0.77369421 |
| 112 | MP0001177_atelectasis | 0.77135664 |
| 113 | MP0002693_abnormal_pancreas_physiology | 0.73782169 |
| 114 | MP0000569_abnormal_digit_pigmentation | 0.72610618 |
| 115 | MP0001664_abnormal_digestion | 0.71861744 |
| 116 | MP0008874_decreased_physiological_sensi | 0.70872475 |
| 117 | MP0005187_abnormal_penis_morphology | 0.68141540 |
| 118 | MP0004085_abnormal_heartbeat | 0.67282342 |
| 119 | MP0003195_calcinosis | 0.66621152 |
| 120 | MP0003634_abnormal_glial_cell | 0.65702778 |
| 121 | MP0006292_abnormal_olfactory_placode | 0.63123428 |
| 122 | MP0003861_abnormal_nervous_system | 0.62968386 |
| 123 | MP0005410_abnormal_fertilization | 0.59765216 |
| 124 | MP0003632_abnormal_nervous_system | 0.58762852 |
| 125 | MP0001299_abnormal_eye_distance/ | 0.56554005 |
| 126 | MP0003137_abnormal_impulse_conducting | 0.56211933 |
| 127 | MP0000920_abnormal_myelination | 0.55999835 |
| 128 | MP0003956_abnormal_body_size | 0.52270185 |
| 129 | MP0000538_abnormal_urinary_bladder | 0.52095193 |
| 130 | MP0005409_darkened_coat_color | 0.51864184 |
| 131 | MP0003698_abnormal_male_reproductive | 0.51683801 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.40187976 |
| 2 | Myokymia (HP:0002411) | 6.14403842 |
| 3 | Congenital stationary night blindness (HP:0007642) | 5.26033283 |
| 4 | Focal seizures (HP:0007359) | 4.75572970 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.47165886 |
| 6 | Visual hallucinations (HP:0002367) | 4.27182416 |
| 7 | Pancreatic fibrosis (HP:0100732) | 4.20148605 |
| 8 | Molar tooth sign on MRI (HP:0002419) | 4.13117466 |
| 9 | Abnormality of midbrain morphology (HP:0002418) | 4.13117466 |
| 10 | Increased circulating renin level (HP:0000848) | 3.99318904 |
| 11 | Febrile seizures (HP:0002373) | 3.91537022 |
| 12 | Pancreatic cysts (HP:0001737) | 3.86255626 |
| 13 | Atonic seizures (HP:0010819) | 3.82862703 |
| 14 | Hyperventilation (HP:0002883) | 3.59619313 |
| 15 | Progressive cerebellar ataxia (HP:0002073) | 3.58898634 |
| 16 | Absence seizures (HP:0002121) | 3.58058955 |
| 17 | Type II lissencephaly (HP:0007260) | 3.50134005 |
| 18 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.50004100 |
| 19 | True hermaphroditism (HP:0010459) | 3.47233715 |
| 20 | Abnormality of macular pigmentation (HP:0008002) | 3.42644152 |
| 21 | Hypoplasia of the fovea (HP:0007750) | 3.32944777 |
| 22 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.32944777 |
| 23 | Generalized tonic-clonic seizures (HP:0002069) | 3.32135610 |
| 24 | Broad-based gait (HP:0002136) | 3.31900710 |
| 25 | Nephronophthisis (HP:0000090) | 3.25230618 |
| 26 | Abnormality of the renal medulla (HP:0100957) | 3.24982685 |
| 27 | Chronic hepatic failure (HP:0100626) | 3.20439081 |
| 28 | Dialeptic seizures (HP:0011146) | 3.17972346 |
| 29 | Abnormality of the renal cortex (HP:0011035) | 3.13148753 |
| 30 | Hypomagnesemia (HP:0002917) | 3.11613651 |
| 31 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 3.11157675 |
| 32 | Limb dystonia (HP:0002451) | 3.06774492 |
| 33 | Metabolic alkalosis (HP:0200114) | 3.03517708 |
| 34 | Action tremor (HP:0002345) | 3.02483066 |
| 35 | Abnormal eating behavior (HP:0100738) | 3.00022704 |
| 36 | Anxiety (HP:0000739) | 2.94938286 |
| 37 | Chorioretinal atrophy (HP:0000533) | 2.94912128 |
| 38 | Supranuclear gaze palsy (HP:0000605) | 2.85120788 |
| 39 | Poor eye contact (HP:0000817) | 2.83914311 |
| 40 | Severe visual impairment (HP:0001141) | 2.78176601 |
| 41 | Abolished electroretinogram (ERG) (HP:0000550) | 2.74589702 |
| 42 | Ankle clonus (HP:0011448) | 2.73145514 |
| 43 | Albinism (HP:0001022) | 2.70798883 |
| 44 | Hypokalemic alkalosis (HP:0001949) | 2.70444450 |
| 45 | Polyuria (HP:0000103) | 2.70367114 |
| 46 | Mutism (HP:0002300) | 2.68136026 |
| 47 | Polyphagia (HP:0002591) | 2.67505689 |
| 48 | Abnormality of the fovea (HP:0000493) | 2.67285252 |
| 49 | Renal cortical cysts (HP:0000803) | 2.66148475 |
| 50 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.65985707 |
| 51 | Abnormality of magnesium homeostasis (HP:0004921) | 2.65953707 |
| 52 | Hyperactive renin-angiotensin system (HP:0000841) | 2.65101066 |
| 53 | Gaze-evoked nystagmus (HP:0000640) | 2.63805675 |
| 54 | Gout (HP:0001997) | 2.63044256 |
| 55 | Amblyopia (HP:0000646) | 2.62172587 |
| 56 | Tubular atrophy (HP:0000092) | 2.61546723 |
| 57 | Abnormal drinking behavior (HP:0030082) | 2.60427236 |
| 58 | Polydipsia (HP:0001959) | 2.60427236 |
| 59 | Pheochromocytoma (HP:0002666) | 2.56529003 |
| 60 | Epileptiform EEG discharges (HP:0011182) | 2.54902670 |
| 61 | Attenuation of retinal blood vessels (HP:0007843) | 2.52300071 |
| 62 | Drooling (HP:0002307) | 2.52216970 |
| 63 | Excessive salivation (HP:0003781) | 2.52216970 |
| 64 | Fetal akinesia sequence (HP:0001989) | 2.49069156 |
| 65 | Torticollis (HP:0000473) | 2.48811920 |
| 66 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.48799355 |
| 67 | Abnormal social behavior (HP:0012433) | 2.48681791 |
| 68 | Impaired social interactions (HP:0000735) | 2.48681791 |
| 69 | Short tibia (HP:0005736) | 2.48246616 |
| 70 | Dysmetria (HP:0001310) | 2.47734936 |
| 71 | Abnormal urine output (HP:0012590) | 2.46926912 |
| 72 | Central scotoma (HP:0000603) | 2.45070361 |
| 73 | EEG with generalized epileptiform discharges (HP:0011198) | 2.44803664 |
| 74 | Depression (HP:0000716) | 2.42994548 |
| 75 | Dysdiadochokinesis (HP:0002075) | 2.42804938 |
| 76 | Focal dystonia (HP:0004373) | 2.41954347 |
| 77 | Urinary urgency (HP:0000012) | 2.40334011 |
| 78 | Papilledema (HP:0001085) | 2.38417432 |
| 79 | Genital tract atresia (HP:0001827) | 2.37081046 |
| 80 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.36982981 |
| 81 | Abnormality of the corticospinal tract (HP:0002492) | 2.36541864 |
| 82 | Spastic gait (HP:0002064) | 2.36074638 |
| 83 | Postural instability (HP:0002172) | 2.32870146 |
| 84 | Gait imbalance (HP:0002141) | 2.32047712 |
| 85 | Abnormality of renal excretion (HP:0011036) | 2.32034496 |
| 86 | Lissencephaly (HP:0001339) | 2.31359740 |
| 87 | Cystic liver disease (HP:0006706) | 2.31238738 |
| 88 | Hypsarrhythmia (HP:0002521) | 2.29979478 |
| 89 | Truncal ataxia (HP:0002078) | 2.29155929 |
| 90 | Pachygyria (HP:0001302) | 2.27655514 |
| 91 | Fair hair (HP:0002286) | 2.26168739 |
| 92 | Craniofacial dystonia (HP:0012179) | 2.24967779 |
| 93 | Hemiparesis (HP:0001269) | 2.22922300 |
| 94 | Abnormality of renin-angiotensin system (HP:0000847) | 2.22554932 |
| 95 | Neurofibrillary tangles (HP:0002185) | 2.21532595 |
| 96 | Progressive inability to walk (HP:0002505) | 2.20013008 |
| 97 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.19772687 |
| 98 | Neuroendocrine neoplasm (HP:0100634) | 2.15524762 |
| 99 | Inability to walk (HP:0002540) | 2.15523403 |
| 100 | Cerebral inclusion bodies (HP:0100314) | 2.15410388 |
| 101 | Decreased central vision (HP:0007663) | 2.15207088 |
| 102 | Cerebellar dysplasia (HP:0007033) | 2.14863679 |
| 103 | Scanning speech (HP:0002168) | 2.13940753 |
| 104 | Status epilepticus (HP:0002133) | 2.12899410 |
| 105 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.12438550 |
| 106 | Agitation (HP:0000713) | 2.12001521 |
| 107 | Severe muscular hypotonia (HP:0006829) | 2.11180603 |
| 108 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.10407278 |
| 109 | Termporal pattern (HP:0011008) | 2.10363553 |
| 110 | Insidious onset (HP:0003587) | 2.10363553 |
| 111 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.09345374 |
| 112 | Anterior segment dysgenesis (HP:0007700) | 2.09173573 |
| 113 | Scotoma (HP:0000575) | 2.07457229 |
| 114 | Hyperaldosteronism (HP:0000859) | 2.04631845 |
| 115 | Absent speech (HP:0001344) | 2.04069309 |
| 116 | Bradykinesia (HP:0002067) | 2.03442185 |
| 117 | Stomach cancer (HP:0012126) | 2.01759868 |
| 118 | Protruding tongue (HP:0010808) | 2.01232204 |
| 119 | Sclerocornea (HP:0000647) | 2.00618051 |
| 120 | Generalized myoclonic seizures (HP:0002123) | 1.99620031 |
| 121 | Hypoplasia of the pons (HP:0012110) | 1.98911521 |
| 122 | Abnormality of chloride homeostasis (HP:0011422) | 1.98532714 |
| 123 | Congenital sensorineural hearing impairment (HP:0008527) | 1.98155995 |
| 124 | Pendular nystagmus (HP:0012043) | 1.97605778 |
| 125 | Retinal dysplasia (HP:0007973) | 1.97386767 |
| 126 | Furrowed tongue (HP:0000221) | 1.96895510 |
| 127 | Vaginal atresia (HP:0000148) | 1.96707543 |
| 128 | Tetany (HP:0001281) | 1.95825799 |
| 129 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.95019885 |
| 130 | Genetic anticipation (HP:0003743) | 1.93572435 |
| 131 | Metaphyseal dysplasia (HP:0100255) | 1.93102534 |
| 132 | Keratoconus (HP:0000563) | 1.91616743 |
| 133 | Increased corneal curvature (HP:0100692) | 1.91616743 |
| 134 | Megalencephaly (HP:0001355) | 1.91538433 |
| 135 | Abnormality of the pons (HP:0007361) | 1.91026092 |
| 136 | Stereotypic behavior (HP:0000733) | 1.89060844 |
| 137 | Congenital hepatic fibrosis (HP:0002612) | 1.87581889 |
| 138 | Impaired smooth pursuit (HP:0007772) | 1.86765605 |
| 139 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.86040655 |
| 140 | Abnormality of alanine metabolism (HP:0010916) | 1.86040655 |
| 141 | Hyperalaninemia (HP:0003348) | 1.86040655 |
| 142 | Widely spaced teeth (HP:0000687) | 1.84500605 |
| 143 | Amyotrophic lateral sclerosis (HP:0007354) | 1.83333304 |
| 144 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.82365602 |
| 145 | Median cleft lip (HP:0000161) | 1.82238458 |
| 146 | Postaxial hand polydactyly (HP:0001162) | 1.80856379 |
| 147 | Akinesia (HP:0002304) | 1.79541082 |
| 148 | Psychosis (HP:0000709) | 1.79332741 |
| 149 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.79313530 |
| 150 | Incomplete penetrance (HP:0003829) | 1.79279007 |
| 151 | Lower limb muscle weakness (HP:0007340) | 1.79264612 |
| 152 | Abnormality of binocular vision (HP:0011514) | 1.79139272 |
| 153 | Diplopia (HP:0000651) | 1.79139272 |
| 154 | Hypothermia (HP:0002045) | 1.77811293 |
| 155 | Ulnar claw (HP:0001178) | 1.77517430 |
| 156 | Postaxial foot polydactyly (HP:0001830) | 1.77383531 |
| 157 | Optic nerve hypoplasia (HP:0000609) | 1.77139977 |
| 158 | Generalized hypopigmentation of hair (HP:0011358) | 1.76027765 |
| 159 | Decreased circulating renin level (HP:0003351) | 1.74052158 |
| 160 | Specific learning disability (HP:0001328) | 1.73127546 |
| 161 | Impaired vibratory sensation (HP:0002495) | 1.72608933 |
| 162 | Nephrogenic diabetes insipidus (HP:0009806) | 1.72248624 |
| 163 | Congenital primary aphakia (HP:0007707) | 1.71788171 |
| 164 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.71668552 |
| 165 | Small hand (HP:0200055) | 1.71495197 |
| 166 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.71020488 |
| 167 | Absent/shortened dynein arms (HP:0200106) | 1.71020488 |
| 168 | Medial flaring of the eyebrow (HP:0010747) | 1.70601746 |
| 169 | Astigmatism (HP:0000483) | 1.70310058 |
| 170 | Anencephaly (HP:0002323) | 1.69907987 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.86080335 |
| 2 | MARK1 | 3.99415069 |
| 3 | NTRK3 | 3.90235537 |
| 4 | EPHA4 | 3.73560070 |
| 5 | MAP3K9 | 3.49224182 |
| 6 | MAP3K4 | 3.00102789 |
| 7 | TAF1 | 2.76496562 |
| 8 | MINK1 | 2.65388299 |
| 9 | MAP2K7 | 2.63068814 |
| 10 | ADRBK2 | 2.61993881 |
| 11 | BMPR1B | 2.39311321 |
| 12 | NTRK2 | 2.26397195 |
| 13 | KSR2 | 2.20046924 |
| 14 | MAP4K2 | 2.15621805 |
| 15 | OXSR1 | 2.15144069 |
| 16 | CASK | 2.14867745 |
| 17 | WNK4 | 2.12770723 |
| 18 | WNK3 | 2.03169345 |
| 19 | DAPK2 | 1.99891925 |
| 20 | MAP3K12 | 1.95276691 |
| 21 | GRK1 | 1.90204008 |
| 22 | KSR1 | 1.88737245 |
| 23 | PAK6 | 1.82987568 |
| 24 | MAP2K4 | 1.81785875 |
| 25 | TAOK3 | 1.81764820 |
| 26 | NTRK1 | 1.76152859 |
| 27 | MAPK13 | 1.69772807 |
| 28 | ACVR1B | 1.67210906 |
| 29 | LATS2 | 1.66023400 |
| 30 | PRKD3 | 1.65267689 |
| 31 | PNCK | 1.62384704 |
| 32 | ARAF | 1.57562220 |
| 33 | TNIK | 1.51220063 |
| 34 | STK38 | 1.47205559 |
| 35 | CDK5 | 1.38656844 |
| 36 | ZAK | 1.32530563 |
| 37 | INSRR | 1.31782197 |
| 38 | PLK2 | 1.30247680 |
| 39 | TRIM28 | 1.28503954 |
| 40 | DAPK1 | 1.26474406 |
| 41 | STK39 | 1.25067771 |
| 42 | PHKG2 | 1.24200547 |
| 43 | PHKG1 | 1.24200547 |
| 44 | GRK5 | 1.19308439 |
| 45 | PRKCG | 1.16666702 |
| 46 | RIPK4 | 1.15394548 |
| 47 | CAMKK1 | 1.12857672 |
| 48 | SGK223 | 1.12081356 |
| 49 | SGK494 | 1.12081356 |
| 50 | MAP3K6 | 1.08175887 |
| 51 | TLK1 | 1.04769038 |
| 52 | NUAK1 | 1.03168336 |
| 53 | CAMK2A | 1.02687952 |
| 54 | CDK19 | 1.01837911 |
| 55 | CSNK1G2 | 1.01708673 |
| 56 | MAP3K2 | 0.98220794 |
| 57 | NME1 | 0.95009562 |
| 58 | NEK1 | 0.94302179 |
| 59 | MUSK | 0.93659626 |
| 60 | ADRBK1 | 0.93334585 |
| 61 | BMPR2 | 0.92742697 |
| 62 | MAP3K13 | 0.92193269 |
| 63 | MKNK2 | 0.90608492 |
| 64 | UHMK1 | 0.88087545 |
| 65 | MAPK15 | 0.85529325 |
| 66 | STK38L | 0.85071649 |
| 67 | CDK18 | 0.84712434 |
| 68 | PINK1 | 0.84258903 |
| 69 | SIK2 | 0.82452321 |
| 70 | TAOK1 | 0.82372178 |
| 71 | PAK3 | 0.81728542 |
| 72 | CDK14 | 0.81428915 |
| 73 | DYRK2 | 0.81023150 |
| 74 | CDK15 | 0.79637600 |
| 75 | BRAF | 0.78667112 |
| 76 | RAF1 | 0.78525169 |
| 77 | PRPF4B | 0.78183038 |
| 78 | SGK2 | 0.76501242 |
| 79 | PRKCQ | 0.74926088 |
| 80 | CAMKK2 | 0.74436776 |
| 81 | STK11 | 0.73813404 |
| 82 | DYRK1A | 0.73314677 |
| 83 | MARK2 | 0.72348255 |
| 84 | CAMK2B | 0.72309898 |
| 85 | RET | 0.70921598 |
| 86 | PIK3CA | 0.68536135 |
| 87 | CDK11A | 0.67815749 |
| 88 | SGK1 | 0.67347789 |
| 89 | PDK3 | 0.65893620 |
| 90 | PDK4 | 0.65893620 |
| 91 | PTK2B | 0.65779716 |
| 92 | FES | 0.65299431 |
| 93 | MAPK12 | 0.64753683 |
| 94 | TYRO3 | 0.63264519 |
| 95 | WNK1 | 0.59409180 |
| 96 | MAPKAPK3 | 0.59157855 |
| 97 | CCNB1 | 0.59001318 |
| 98 | SIK3 | 0.57773914 |
| 99 | CAMK1 | 0.56607110 |
| 100 | PRKCZ | 0.55011996 |
| 101 | TIE1 | 0.54461506 |
| 102 | PRKG1 | 0.52954279 |
| 103 | PRKCI | 0.51274026 |
| 104 | MARK3 | 0.51179498 |
| 105 | FER | 0.51162530 |
| 106 | CSNK1G3 | 0.50769982 |
| 107 | MAPKAPK5 | 0.50283963 |
| 108 | TXK | 0.48867750 |
| 109 | SGK3 | 0.47728495 |
| 110 | TRPM7 | 0.47302713 |
| 111 | PRKCE | 0.46233233 |
| 112 | STK3 | 0.45264244 |
| 113 | MST4 | 0.45071550 |
| 114 | LMTK2 | 0.44879813 |
| 115 | BCR | 0.43483771 |
| 116 | ERBB3 | 0.42030670 |
| 117 | CSNK1A1 | 0.41434094 |
| 118 | MAP3K1 | 0.41231565 |
| 119 | STK24 | 0.40953552 |
| 120 | FGFR2 | 0.39906004 |
| 121 | PDPK1 | 0.39464322 |
| 122 | PRKD1 | 0.39456565 |
| 123 | PDK1 | 0.39230251 |
| 124 | KIT | 0.38629199 |
| 125 | IKBKB | 0.37563088 |
| 126 | MAPK7 | 0.37551824 |
| 127 | RPS6KA3 | 0.36903514 |
| 128 | CAMK2G | 0.36361949 |
| 129 | MAP2K1 | 0.35966138 |
| 130 | TGFBR1 | 0.35765279 |
| 131 | PRKCA | 0.35377668 |
| 132 | CDK3 | 0.35299745 |
| 133 | CAMK2D | 0.34278705 |
| 134 | MAPK10 | 0.34197194 |
| 135 | PRKCH | 0.33853565 |
| 136 | PRKACA | 0.33824307 |
| 137 | BCKDK | 0.32701208 |
| 138 | PKN1 | 0.31448884 |
| 139 | IGF1R | 0.30863931 |
| 140 | RPS6KB1 | 0.30810604 |
| 141 | CSNK1G1 | 0.29760927 |
| 142 | PRKACB | 0.29505411 |
| 143 | CSNK1A1L | 0.29400667 |
| 144 | STK16 | 0.29397564 |
| 145 | CSNK1D | 0.29080871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.86875437 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.34543226 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.66996915 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.63528335 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.60472238 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.54831166 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.53481990 |
| 8 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.52617551 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.51985240 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.50821800 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.45223283 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.38242141 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.17137697 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.09115239 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 2.01160318 |
| 16 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.99343520 |
| 17 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.98378844 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.98090988 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.94022763 |
| 20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.93729911 |
| 21 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.81256241 |
| 22 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.80798676 |
| 23 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.75015176 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.74553772 |
| 25 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.68289954 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.67705563 |
| 27 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.66317394 |
| 28 | Cocaine addiction_Homo sapiens_hsa05030 | 1.62831183 |
| 29 | Renin secretion_Homo sapiens_hsa04924 | 1.58616131 |
| 30 | ABC transporters_Homo sapiens_hsa02010 | 1.57671268 |
| 31 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.53751128 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.53446183 |
| 33 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.52296868 |
| 34 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.49936780 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.49467374 |
| 36 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.45954424 |
| 37 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.45207677 |
| 38 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.42786227 |
| 39 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.41585440 |
| 40 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.41416039 |
| 41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.35092525 |
| 42 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.34802495 |
| 43 | Gap junction_Homo sapiens_hsa04540 | 1.34002311 |
| 44 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.30806750 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.23246365 |
| 46 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.22135014 |
| 47 | Basal transcription factors_Homo sapiens_hsa03022 | 1.19376213 |
| 48 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.14857306 |
| 49 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.14747540 |
| 50 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.13007738 |
| 51 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.11447185 |
| 52 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.10289124 |
| 53 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.09834474 |
| 54 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.09598641 |
| 55 | Axon guidance_Homo sapiens_hsa04360 | 1.08003539 |
| 56 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.05095990 |
| 57 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.04383625 |
| 58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04056759 |
| 59 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.99765817 |
| 60 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.99091810 |
| 61 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.98806486 |
| 62 | Homologous recombination_Homo sapiens_hsa03440 | 0.98506735 |
| 63 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.97911967 |
| 64 | Phototransduction_Homo sapiens_hsa04744 | 0.96895518 |
| 65 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.96083478 |
| 66 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.94568491 |
| 67 | Alzheimers disease_Homo sapiens_hsa05010 | 0.92996590 |
| 68 | Glioma_Homo sapiens_hsa05214 | 0.90941323 |
| 69 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.90197658 |
| 70 | Histidine metabolism_Homo sapiens_hsa00340 | 0.88150394 |
| 71 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.87894271 |
| 72 | Melanogenesis_Homo sapiens_hsa04916 | 0.87718580 |
| 73 | Parkinsons disease_Homo sapiens_hsa05012 | 0.86468862 |
| 74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86214065 |
| 75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.85392135 |
| 76 | Retinol metabolism_Homo sapiens_hsa00830 | 0.84896958 |
| 77 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.83751754 |
| 78 | Protein export_Homo sapiens_hsa03060 | 0.83728028 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.82198533 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80095405 |
| 81 | Peroxisome_Homo sapiens_hsa04146 | 0.77311397 |
| 82 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74959278 |
| 83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73978427 |
| 84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.73656109 |
| 85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.71835063 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71739079 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71525853 |
| 88 | Circadian rhythm_Homo sapiens_hsa04710 | 0.67417275 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65030976 |
| 90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63913144 |
| 91 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63186076 |
| 92 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.62421847 |
| 93 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.62349504 |
| 94 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.62279469 |
| 95 | Huntingtons disease_Homo sapiens_hsa05016 | 0.61716824 |
| 96 | Bile secretion_Homo sapiens_hsa04976 | 0.61386042 |
| 97 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.58502267 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.57376518 |
| 99 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.56521727 |
| 100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55900206 |
| 101 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53189758 |
| 102 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52340059 |
| 103 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.52271129 |
| 104 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.51109079 |
| 105 | Lysine degradation_Homo sapiens_hsa00310 | 0.50778706 |
| 106 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.50017848 |
| 107 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.49715447 |
| 108 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.48933171 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.48833598 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.47286599 |
| 111 | Alcoholism_Homo sapiens_hsa05034 | 0.46897261 |
| 112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45974808 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45474257 |
| 114 | Asthma_Homo sapiens_hsa05310 | 0.43661135 |
| 115 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42695994 |
| 116 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42138576 |
| 117 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41692674 |
| 118 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.41457923 |
| 119 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.40772243 |
| 120 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40029743 |
| 121 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38369860 |
| 122 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.37964441 |
| 123 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.37317794 |
| 124 | Purine metabolism_Homo sapiens_hsa00230 | 0.36668215 |
| 125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35847287 |
| 126 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.35338145 |
| 127 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.35226545 |
| 128 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.35157489 |
| 129 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.34505055 |
| 130 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.33856203 |
| 131 | Mineral absorption_Homo sapiens_hsa04978 | 0.33507810 |
| 132 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.32889159 |
| 133 | RNA degradation_Homo sapiens_hsa03018 | 0.32840780 |
| 134 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32544266 |
| 135 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.32383923 |
| 136 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.32196416 |
| 137 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.32151406 |
| 138 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.31437077 |
| 139 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29612473 |
| 140 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.29262355 |
| 141 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.27185446 |
| 142 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.26758992 |
| 143 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.25787219 |
| 144 | Endocytosis_Homo sapiens_hsa04144 | 0.22589775 |

